Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors
In recent years, progress has been made in understanding the pathological, genetic, and molecular heterogeneity of central nervous system (CNS) tumors. However, improvements in risk classification, prognosis, and treatment have not been sufficient. Currently, great importance has been placed to the...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2019-01-01
|
| Series: | BioMed Research International |
| Online Access: | http://dx.doi.org/10.1155/2019/5286358 |